Axios @axios
@caitlinnowens @sam_baker @RepSchrader @KashyappatelMd .@KashyappatelMd: "The price takes its own toll on cancer patients with [more] patients facing out-of-pocket costs. It becomes hard for them to sustain the level of cancer care. I think biosimilars definitely help assimilate some of that kind of challenge." https://t.co/Xw6s6RWOZp — PolitiTweet.org